JOHANNESBURG (Reuters) – Johnson & Johnson will be exporting more ready-to-administer doses to the South African government beyond the 300,000 that was been announced by the local drug regulator on Sunday, CEO of Aspen Pharmacare said on Monday.
Aspen is the local manufacturer of J&J’s COVID-19 vaccine.
(Reporting by Promit Mukherjee; Editing by Emma Rumney)
